10-Q: US Physical Therapy Reports Q2 2026 Results, Revenue Up

U.S. Physical Therapy, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting an increase in net revenue driven by physical therapy and industrial injury prevention services.

Summary

• U.S. Physical Therapy, Inc. reported net income attributable to shareholders of $9.9 million for the 2026 Second Quarter, down from $12.4 million in the prior year period.
• Earnings per share were $0.25 for the 2026 Second Quarter, compared to $0.58 in the 2025 Second Quarter.
• Total net revenue for the 2026 Second Quarter increased by 8.5% to $214.1 million from $197.3 million in the 2025 Second Quarter.
• Operating costs increased by 10.5% to $172.1 million.
• Gross profit saw a slight increase of 0.8% to $41.9 million.
• For the six months ended June 30, 2026, net income attributable to shareholders was $14.9 million, down from $22.3 million in the prior year period.
• Earnings per share for the six months were $0.13, compared to $1.38 in the prior year period.
• Net revenue for the six months increased by 8.2% to $412.3 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing, with revenue growth and strategic acquisitions offsetting some margin pressures and increased interest expenses.

Positives

• Net revenue increased by 8.5% to $214.1 million for the second quarter and by 8.2% to $412.3 million for the first six months.
• Physical therapy operations revenue grew 8.4% year-over-year for the second quarter, with a 3.5% increase in mature revenue.
• Industrial Injury Prevention (IIP) revenue increased by 9.1% for the second quarter and 10.4% for the six-month period.
• Total patient visits increased by 6.6% in the second quarter and 6.7% for the six-month period.
• The company completed two acquisitions in January 2026, adding 8 clinics to its portfolio.
• A new $450.0 million credit facility was secured on April 14, 2026, providing increased financial flexibility.
• The company declared a quarterly dividend of $0.46 per share, payable on September 11, 2026.

Negatives

• Net income attributable to shareholders decreased by 20.1% to $9.9 million for the second quarter and by 33.0% to $14.9 million for the six-month period.
• Earnings per share decreased significantly to $0.25 for the second quarter and $0.13 for the six-month period.
• Gross profit margin for physical therapy operations decreased to 19.5% in Q2 2026 from 21.2% in Q2 2025.
• Corporate office costs increased by 8.7% for the second quarter and 10.6% for the six-month period.
• The company experienced a loss on the change in fair value of contingent earn-out consideration of $1.0 million in Q2 2026, compared to a gain of $0.8 million in Q2 2025.
• Interest expense increased by 32.7% in Q2 2026 and 27.7% for the six-month period due to higher outstanding balances on the revolving credit facility.

Risks

• Changes in Medicare rules and reimbursement rates, and potential retroactive reductions.
• Changes in reimbursement methods from third-party payors and potential increases in patient deductibles and co-pays.
• Compliance with state laws regarding the corporate practice of medicine and fee splitting.
• Competitive, economic, or reimbursement conditions that may necessitate clinic reorganizations or closures.
• Potential impact of future public health crises, epidemics, or pandemics.
• Debt and financial obligations could adversely affect financial condition and ability to obtain future financing.
• Potential for legal actions, which could result in increased operating costs and uninsured liabilities.
• Cybersecurity risks and potential breaches of information technology systems.

Future Outlook

The company plans to continue acquiring multi-clinic outpatient physical therapy practices and IIP companies, and developing new clinics. Management believes current cash and credit facilities are sufficient to fund working capital needs through at least June 30, 2027.

Management Comments

• The company changed its salaries and related costs metric from cost-per-visit to percentage-of-revenue, believing it to be a more meaningful presentation.
• Implementation costs associated with the new financial and human resources system are expected to continue through the end of 2026.

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy's performance reflects broader trends in the healthcare services sector, including consolidation through acquisitions and the impact of evolving reimbursement policies. The company's diversified revenue streams across physical therapy and industrial injury prevention services provide some resilience.

Comparison to Industry Standards

• The company's gross profit margin for physical therapy operations (19.5% in Q2 2026) is within a typical range for outpatient therapy providers, though it has seen a slight decrease year-over-year.
• Revenue growth of 8.5% in Q2 2026 aligns with industry trends of expansion through acquisition and organic growth in the healthcare services sector.
• The effective interest rate on the company's Senior Credit Facilities (5.3% in Q2 2026) is comparable to rates for similarly leveraged companies in the healthcare sector, influenced by prevailing market conditions.
• The company's strategy of acquiring smaller practices and IIP businesses is a common approach in the fragmented physical therapy market, aiming for scale and efficiency.

Legal Proceedings

• The company is involved in various legal actions, proceedings, claims, and regulatory audits/investigations in the ordinary course of business.
• These matters could potentially lead to sanctions, damages, recoupments, fines, and penalties.
• The company has been and may continue to be a defendant in qui tam lawsuits under the federal False Claims Act.

Related Party Transactions

• The company leases properties from Michael G. Mayrsohn, President of Metro and a Director on the Company's Board.
• Lease payments to Mr. Mayrsohn totaled $0.2 million for the six months ended June 30, 2026.
• Minimum future rental payments under these related party leases total $2.4 million as of June 30, 2026.

Stakeholder Impact

• Shareholders may experience reduced returns due to lower net income and EPS, though dividends are being maintained.
• Employees may be impacted by the ongoing integration of acquired businesses and system upgrades.
• Creditors are impacted by the company's increased debt levels and the new credit facility.
• Patients continue to receive physical and industrial injury prevention services, with revenue growth indicating sustained demand.

Next Steps

• Continue to integrate the 60 clinics from the New York hospital system alliance, expected through September 30, 2026.
• Continue integration of 10 clinics from another hospital system alliance, expected in the three months ending September 30, 2026.
• Continue implementation of new financial and human resources system through the end of 2026.
• Monitor and manage the impact of ongoing regulatory changes in healthcare reimbursement.
• Continue to evaluate and pursue strategic acquisitions and development of new clinics.

Key Dates

Recommendation

While revenue growth and strategic acquisitions are positive, the decline in net income and EPS, coupled with margin pressures in the physical therapy segment, warrants a cautious approach. The company's ability to manage increased interest expenses and integrate new acquisitions effectively will be key.

Keywords

physical therapy, outpatient clinics, industrial injury prevention, healthcare services, acquisitions, revenue growth, reimbursement, corporate governance